Abstract:The origin and intermediate host for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is yet to be determined. Coronaviruses found to be closely related to SARS-CoV-2 include RaTG13 derived from bat and two clusters (PCoV-GD and PCoV-GX) of coronaviruses identified in pangolin. Here, we studied the infectivity and antigenicity patterns of SARS-CoV-2 and the three related coronaviruses. Compared with the other three viruses, RaTG13 showed almost no infectivity to a variety of cell lines. The two pan… Show more
“…SARS-CoV-2 was found to be most closely related genetically to a horseshoe bat coronavirus called CoV-RaTG13 that was isolated in Yunnan province, China, with 96.2% nucleotide identity between the two viruses [ 1 ]. An intermediate host for SARS-CoV-2 has not been conclusively identified, although pangolins have emerged as a potential culprit [ 27 , 28 , 29 ]. Interestingly, SARS-CoV-2 contains a spike protein receptor binding domain (RBD) and polybasic furin cleavage site that are distinct from CoV-RaTG13; the RBD is directly involved in its cellular entry mechanism through binding to the human angiotensin-converting enzyme 2 (hACE2) receptor, followed by cleavage at the furin cleavage site by the TMPRRS2 transmembrane serine protease [ 1 , 30 , 31 ].…”
SARS-CoV-2 is the etiological agent responsible for the ongoing COVID-19 pandemic, which continues to spread with devastating effects on global health and socioeconomics. The susceptibility of domestic and wild animal species to infection is a critical facet of SARS-CoV-2 ecology, since reverse zoonotic spillover events resulting in SARS-CoV-2 outbreaks in animal populations could result in the establishment of new virus reservoirs. Adaptive mutations in the virus to new animal species could also complicate ongoing mitigation strategies to combat SARS-CoV-2. In addition, animal species susceptible to SARS-CoV-2 infection are essential as standardized preclinical models for the development and efficacy testing of vaccines and therapeutics. In this review, we summarize the current findings regarding the susceptibility of different domestic and wild animal species to experimental SARS-CoV-2 infection and provide detailed descriptions of the clinical disease and transmissibility in these animals. In addition, we outline the documented natural infections in animals that have occurred at the human–animal interface. A comprehensive understanding of animal susceptibility to SARS-CoV-2 is crucial to inform public health, veterinary, and agricultural systems, and to guide environmental policies.
“…SARS-CoV-2 was found to be most closely related genetically to a horseshoe bat coronavirus called CoV-RaTG13 that was isolated in Yunnan province, China, with 96.2% nucleotide identity between the two viruses [ 1 ]. An intermediate host for SARS-CoV-2 has not been conclusively identified, although pangolins have emerged as a potential culprit [ 27 , 28 , 29 ]. Interestingly, SARS-CoV-2 contains a spike protein receptor binding domain (RBD) and polybasic furin cleavage site that are distinct from CoV-RaTG13; the RBD is directly involved in its cellular entry mechanism through binding to the human angiotensin-converting enzyme 2 (hACE2) receptor, followed by cleavage at the furin cleavage site by the TMPRRS2 transmembrane serine protease [ 1 , 30 , 31 ].…”
SARS-CoV-2 is the etiological agent responsible for the ongoing COVID-19 pandemic, which continues to spread with devastating effects on global health and socioeconomics. The susceptibility of domestic and wild animal species to infection is a critical facet of SARS-CoV-2 ecology, since reverse zoonotic spillover events resulting in SARS-CoV-2 outbreaks in animal populations could result in the establishment of new virus reservoirs. Adaptive mutations in the virus to new animal species could also complicate ongoing mitigation strategies to combat SARS-CoV-2. In addition, animal species susceptible to SARS-CoV-2 infection are essential as standardized preclinical models for the development and efficacy testing of vaccines and therapeutics. In this review, we summarize the current findings regarding the susceptibility of different domestic and wild animal species to experimental SARS-CoV-2 infection and provide detailed descriptions of the clinical disease and transmissibility in these animals. In addition, we outline the documented natural infections in animals that have occurred at the human–animal interface. A comprehensive understanding of animal susceptibility to SARS-CoV-2 is crucial to inform public health, veterinary, and agricultural systems, and to guide environmental policies.
“…Moreover, SARS-CoV-2 has been shown to infect efficiently 293T and Vero cells without human ACE2 transfection 12,40 . Therefore, it could be inferred that the SARS-CoV-2-S1-RBD and FCS might be the cause for the severity of the infection and in addition, some other factors also contribute to the increased transmissibility of infection in humans which is the hallmark for the SARS-CoV-2 in comparison to SARS-CoV-1 and MERS-CoV.…”
Section: Discussionmentioning
confidence: 99%
“…The pseudotyped virus of S protein RatG13 has a poor ability to infect many cell types, including bat and human cells 23,40 . The RaTG13 is the only one bat virus RNA sequence having the Type-I-S1-NTD remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…The RaTG13 is the only one bat virus RNA sequence having the Type-I-S1-NTD remains unknown. It could be due to (i) Reverse zoonosis of human-specific Type-I-S1-NTD to bats, as SARS-CoV-2 is known to cause reverse zoonosis [57][58][59][60][61][62][63] ; or (ii) Contamination of human virus to bat sample during sample collection, transport, storage, and sample processing, and this theory might be disproved by isolation of the virus and experimental infection; or (iii) The RaTG13 virus may spontaneously evolve in bats; however, the RaTG13 (with Type-I-S1-NTD) and Pangolin/GX/2018 lineage (with Type-I-like-S1-NTD) S gene pseudotyped viruses fail to infect bat cells 40 ; whereas, Pangolin/Guangdong/2019 lineage (with TypeII-like-S1-NTD) efficiently infect the bat cells 40 . Therefore, it can be inferred that the Type-I-S1-NTD is the most potential for enhancing human adaptation.…”
The clue behind the emergence of SARS-CoV-2 remains a huge debate among the virologist, policymakers, and general public, while the gain-of-function hypothesizes mostly focused on the furin cleavage site and receptor-binding domain (RBD) of the spike (S) protein. Here, we report that the SARS-CoV-2 gained the novel human-specific spike protein S1-N-Terminal Domain (S1-NTD) (Type-I) which is present only in SARS-CoV-2. Interestingly, SARS-CoV-2-rB-CoV showed unique bat-specific Type-II and Type-III-S1-NTD, which is not present in other SARS coronaviruses, including SARS-CoV-2 variants. We also found widespread recombination and selection pressure in the S1-NTDs of the bat viruses. In addition, the Pangolin/GX/2018 and Pangolin/Guangdong/2019 lineages showed close identity (73-79%) with the Type-I-S1-NTD and Type-II-S1-NTD respectively. This justifies that the pangolin is the mixing vessel (intermediate host) to exchange the bat-specific Type-II-S1-NTD in the SARS-CoV-2-rB-CoV into Type-I-like-S1-NTD in pangolin through recombination. Furthermore, the pangolin virus with Type-I-like-S1-NTD jumped into humans which then transformed into SARS-CoV-2 with Type-I-S1-NTD by host selection pressure. Remarkably, we characterized the bat/Cambodia virus as a recombinant SARS-CoV-2/RatG13 with the S1-NTD of bat-SARS-like viruses; while only bat/RatG13 with Type-I-S1-NTD established a huge pandemic outbreak. Additionally, recent SARS-CoV-2 S1-NTD specific neutralizing antibody-based studies support the role of S1-NTD in the post-attachment of the virus; fusion, virus dissemination, and cell-cell fusion thereby prevent the onset of infection; and most of the SARS-CoV-2 variants with increased transmissibility were linked to the S1-NTD mutations. Collectively, our results strongly suggest that the gain of Type-I-S1-NTD in the SARS-CoV-2 is the reason for the pandemic outbreak.
“…Currently, M. javanica is the only known pangolin species that harbors coronaviruses closely related to SARS-CoV-2. Although the pangolin-CoVs tend to be more distantly related to SARS-CoV-2 than the aforementioned bat-derived SC2r-CoVs, recent studies show that the receptor-binding domain (RBD) of both pangolin-CoV sublineages can potentially bind the human ACE2 receptor ( Dicken et al, 2021 ; Guo et al, 2021 ; Nie et al, 2021 ; Niu et al, 2021 ; Zhang et al, 2021 ), raising concerns about the potential risks of spillover of these pangolin-CoVs to humans.…”
Understanding the zoonotic origin and evolution history of SARS-CoV-2 will provide critical insights for alerting and preventing future outbreaks. A significant gap remains for the possible role of pangolins as a reservoir of SARS-CoV-2 related coronaviruses (SC2r-CoVs). Here, we screened SC2r-CoVs in 172 samples from 163 pangolin individuals of four species, and detected positive signals in muscles of four
Manis javanica
and, for the first time, one
M. pentadactyla
. Phylogeographic analysis of pangolin mitochondrial DNA traced their origins from Southeast Asia. Using in-solution hybridization capture sequencing, we assembled a partial pangolin SC2r-CoV (pangolin-CoV) genome sequence of 22895 bp (MP20) from the
M. pentadactyla
sample. Phylogenetic analyses revealed MP20 was very closely related to pangolin-CoVs that were identified in
M. javanica
seized by Guangxi Customs. A genetic contribution of bat coronavirus to pangolin-CoVs via recombination was indicated. Our analysis revealed that the genetic diversity of pangolin-CoVs is substantially higher than previously anticipated. Given the potential infectivity of pangolin-CoVs, the high genetic diversity of pangolin-CoVs alerts the ecological risk of zoonotic evolution and transmission of pathogenic SC2r-CoVs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.